These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 14707990)

  • 21. Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema.
    Gupta A; Gupta V; Thapar S; Bhansali A
    Am J Ophthalmol; 2004 Apr; 137(4):675-82. PubMed ID: 15059707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Statins as a new therapeutic possibility in osteoporosis? Wishful thinking as opposed to data].
    Barthel HR
    Dtsch Med Wochenschr; 2001 Oct; 126(42):1189-90. PubMed ID: 11607863
    [No Abstract]   [Full Text] [Related]  

  • 23. Common obstacles in lipid management.
    Elpers M
    Crit Care Nurs Clin North Am; 2008 Sep; 20(3):287-95. PubMed ID: 18644511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Cheng AY; Leiter LA
    Curr Opin Cardiol; 2006 Jul; 21(4):400-4. PubMed ID: 16755211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid lowering effects of statins and fibrates in the management of HIV dyslipidemias associated with antiretroviral therapy in HIV clinical practice.
    Visnegarwala F; Maldonado M; Sajja P; Minihan JL; Rodriguez-Barradas MC; Ong O; Lahart CJ; Hasan MQ; Balasubramanyam A; White AC
    J Infect; 2004 Nov; 49(4):283-90. PubMed ID: 15474625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials.
    Briel M; Studer M; Glass TR; Bucher HC
    Am J Med; 2004 Oct; 117(8):596-606. PubMed ID: 15465509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Various internal medicine aspects of the future therapy for diabetic retinopathy].
    Houtsmuller AJ
    Klin Monbl Augenheilkd; 1972 May; 160(5):521-7. PubMed ID: 5075948
    [No Abstract]   [Full Text] [Related]  

  • 28. [Statins in practice of the vascular surgeon and cardiologist].
    Pokrovskiĭ AV; Suntsov DS
    Angiol Sosud Khir; 2009; 15(2):123-7. PubMed ID: 19806952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease.
    Staels B; Maes M; Zambon A
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):542-53. PubMed ID: 18628776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Starting lipid lowering therapy in the hospital leads to longer-term use, study finds.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Jan; 15(1):8-10. PubMed ID: 14994727
    [No Abstract]   [Full Text] [Related]  

  • 31. Statins and advanced heart failure--alive but barely breathing after CORONA and GISSI-HF.
    Lavie CJ; Mehra MR
    Congest Heart Fail; 2009; 15(4):157-8. PubMed ID: 19627287
    [No Abstract]   [Full Text] [Related]  

  • 32. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery.
    Thielmann M; Neuhäuser M; Marr A; Jaeger BR; Wendt D; Schuetze B; Kamler M; Massoudy P; Erbel R; Jakob H
    J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1143-9. PubMed ID: 17976441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Favorable effects of decreasing lipids in patients with diabetes mellitus].
    Gouni-Berthold I; Krone W
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S252-4. PubMed ID: 17139581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benefits of lipid-lowering therapy in patients with type 2 diabetes mellitus.
    Betteridge J
    Am J Med; 2005 Dec; 118 Suppl 12A():10-5. PubMed ID: 16356802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of fibrates in a statin world.
    Bloomfield HE
    Arch Intern Med; 2006 Apr; 166(7):715-6. PubMed ID: 16606806
    [No Abstract]   [Full Text] [Related]  

  • 36. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
    Ginsberg HN; Bonds DE; Lovato LC; Crouse JR; Elam MB; Linz PE; O'connor PJ; Leiter LA; Weiss D; Lipkin E; Fleg JL;
    Am J Cardiol; 2007 Jun; 99(12A):56i-67i. PubMed ID: 17599426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Was caution the best advice?
    Parchman ML
    J Fam Pract; 2007 Feb; 56(2):112-3; author reply 113. PubMed ID: 17611993
    [No Abstract]   [Full Text] [Related]  

  • 40. The 2003 Canadian recommendations for dyslipidemia management: revisions are needed.
    Manuel DG; Tanuseputro P; Mustard CA; Schultz SE; Anderson GM; Ardal S; Alter DA; Laupacis A
    CMAJ; 2005 Apr; 172(8):1027-31. PubMed ID: 15824409
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.